MANKIND PHARMA LTDMANKIND PHARMA LTDMANKIND PHARMA LTD

MANKIND PHARMA LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪841.26 B‬INR
‪19.13 B‬INR
‪103.35 B‬INR
‪64.42 M‬
Beta (1Y)
0.35

About MANKIND PHARMA LTD

CEO
Sheetal Arora
Headquarters
New Delhi
Founded
1986
ISIN
INE634S01028
FIGI
BBG01G9WXGC8
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. It offers products under the brands of Nurokind, Telmikind, Manforce, Unwanted, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Prega News, Dydroboon, Cefakind, Monticope, and Caldikind. The company was founded by Ramesh Chand Juneja in 1986 and is headquartered in New Delhi, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MANKIND is 2062.80 INR — it has decreased by 1.77% in the past 24 hours. Watch MANKIND PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange MANKIND PHARMA LTD stocks are traded under the ticker MANKIND.
MANKIND stock has fallen by 2.70% compared to the previous week, the month change is a 14.44% fall, over the last year MANKIND PHARMA LTD has showed a 55.21% increase.
We've gathered analysts' opinions on MANKIND PHARMA LTD future price: according to them, MANKIND price has a max estimate of 2520.00 INR and a min estimate of 1800.00 INR. Watch MANKIND chart and read a more detailed MANKIND PHARMA LTD stock forecast: see what analysts think of MANKIND PHARMA LTD and suggest that you do with its stocks.
MANKIND reached its all-time high on Apr 23, 2024 with the price of 2490.00 INR, and its all-time low was 1242.00 INR and was reached on May 22, 2023. View more price dynamics on MANKIND chart.
See other stocks reaching their highest and lowest prices.
MANKIND stock is 3.19% volatile and has beta coefficient of 0.35. Track MANKIND PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is MANKIND PHARMA LTD there?
Today MANKIND PHARMA LTD has the market capitalization of ‪826.59 B‬, it has decreased by 2.92% over the last week.
Yes, you can track MANKIND PHARMA LTD financials in yearly and quarterly reports right on TradingView.
MANKIND PHARMA LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
MANKIND net income for the last quarter is ‪4.71 B‬ INR, while the quarter before that showed ‪4.54 B‬ INR of net income which accounts for 3.85% change. Track more MANKIND PHARMA LTD financial stats to get the full picture.
No, MANKIND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MANKIND PHARMA LTD EBITDA is ‪25.35 B‬ INR, and current EBITDA margin is 24.53%. See more stats in MANKIND PHARMA LTD financial statements.
Like other stocks, MANKIND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MANKIND PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MANKIND PHARMA LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MANKIND PHARMA LTD stock shows the sell signal. See more of MANKIND PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.